Identifying the Evolving Role of Immunotherapy in Advanced/Metastatic NSCLC

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.50
Identification and Management of Immune-Related Adverse Events

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.50
Applying Evidence for Immunotherapy in Resectable Nonmetastatic NSCLC

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.50
Applying Evidence for Immunotherapy in Resectable Nonmetastatic NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Identifying the Evolving Role of Immunotherapy in Advanced/Metastatic NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Identification and Management of Immune-Related Adverse Events in NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Combination Immunotherapy and Chemotherapy Regimens in NSCLC: Clinical Practice Recommendations for Oncology Nurses

Content Format:

Slideset

Credit Type:

--

Credits:

--
Assessing Adverse Events in Patients Receiving Chemoimmunotherapy Regimens for Non-Small-Cell Lung Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
Combination Immunotherapy and Chemotherapy Regimens in NSCLC: Clinical Practice Recommendations for Oncology Nurses

Content Format:

Slideset

Credit Type:

--

Credits:

--
Nursing Perspectives on the Impact of Immune Checkpoint Inhibitors in Early Stages of Cancer

Content Format:

Video

Credit Type:

ANCC

Credits:

1.50
Immune Checkpoint Inhibitors in Early Stages of Cancer: A Guide for Counseling Patients

Content Format:

PDF

Credit Type:

--

Credits:

--
Nursing Perspectives on the Impact of Immune Checkpoint Inhibitors in Early Stages of Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Advances in Immune Checkpoint Inhibitor Therapy for Patients with Non-Small-Cell Lung Cancer: Applications to Clinical Practice

Content Format:

PCE On Demand Live Presentation

Credit Type:

AAPA | ANCC

Credits:

1.00
Importance of Early Recognition and Management of Immune-Related Adverse Events to Optimize Outcomes With Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer and Other Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--